Trials / Recruiting
RecruitingNCT06102382
The Effect of Two Different Doses of Noradrenaline on Hypotension Caused by Spinal Anesthesia for Cesarean Section
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 19 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
To compare two infusion rates of norepinephrine for prophylaxis against post-spinal hypotension during caesarean delivery.
Detailed description
Hypotension after spinal anesthesia for cesarean delivery is common and is caused mainly by peripheral vasodilatation. Although the intravenous administration of fluids helps, it does not always prevent maternal hypotension. Usually, this hypotension is treated with phenylephrine or ephedrine. Norepinephrine has been recently introduced for prophylaxis against post-spinal hypotension during cesarean delivery due to its α-adrenergic activity in addition to the weak β-adrenergic activity. Although the use of norepinephrine for this purpose has shown promising results. However, no sufficient data are available with regard to its optimum dose. The objective of this study is to compare two infusion rates of norepinephrine for prophylaxis against post-spinal hypotension during caesarean delivery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Norepinephrine (0.1) | An intravenous bolus dose of norepinephrine (5 µg) followed by infusion of 0.1 µg/kg/min till 5 minutes after delivery of the fetus. |
| DRUG | Norepinephrine (0.075) | An intravenous bolus dose of norepinephrine (5 µg) followed by infusion of 0.075 µg/kg/min till 5 minutes after delivery of the fetus. |
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2025-10-01
- Completion
- 2025-12-01
- First posted
- 2023-10-26
- Last updated
- 2025-08-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06102382. Inclusion in this directory is not an endorsement.